Literature DB >> 17944950

HIV-associated Kaposi sarcoma: pathogenesis and therapy.

Anja Potthoff1, Norbert H Brockmeyer.   

Abstract

While classical Kaposi sarcoma is a slowly progressing tumor, AIDS-related Kaposi sarcoma is much more aggressive. After introduction of antiretroviral therapy and with the use of well- tolerated chemotherapeutic agents, complete remission of the tumor can be achieved. Local therapeutic options include excision, cryosurgery, radiation and alitretinoin gel. In 45 % of patients with more than 400/microl CD4+ lymphocytes, interferon-alpha induces complete remission. New concepts of pathogenesis lead to therapeutic targets, such as inhibition of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17944950     DOI: 10.1111/j.1610-0387.2007.06567.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  8 in total

1.  Clinical challenge: cutaneous Kaposi's sarcoma of the lower extremity.

Authors:  Erika L Johnson; Yvonne N Pierpont; Guillermo Donate; Mattew H Hiro; Rudolph J Mannari; Theodore J Strickland; Martin C Robson; Wyatt G Payne
Journal:  Int Wound J       Date:  2011-02-11       Impact factor: 3.315

2.  Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus.

Authors:  Lorenzo González-Molleda; Yan Wang; Yan Yuan
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

3.  Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II.

Authors:  Bo Xu; Ling Wang; Lorenzo González-Molleda; Yan Wang; Jun Xu; Yan Yuan
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

4.  Kaposi sarcoma in a HIV uninfected man who has sex with men.

Authors:  Anja Potthoff; N H Brockmeyer; M Stücker; U Wieland; A Kreuter
Journal:  Eur J Med Res       Date:  2010-02-26       Impact factor: 2.175

5.  Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review.

Authors:  Cristina Micali; Ylenia Russotto; Alessio Facciolà; Andrea Marino; Benedetto Maurizio Celesia; Eugenia Pistarà; Grazia Caci; Giuseppe Nunnari; Giovanni Francesco Pellicanò; Emmanuele Venanzi Rullo
Journal:  Infect Dis Rep       Date:  2022-03-25

Review 6.  Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.

Authors:  Kawalpreet K Aneja; Yan Yuan
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

7.  An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes.

Authors:  Canrong Zhong; Mengyang Xu; Yan Wang; Jun Xu; Yan Yuan
Journal:  PLoS Pathog       Date:  2017-04-05       Impact factor: 6.823

8.  Biologics in dermatologic therapy - an update.

Authors:  Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.